MedPath
HSA Approval

ERBETAN FILM-COATED TABLET 150MG

SIN15176P

ERBETAN FILM-COATED TABLET 150MG

ERBETAN FILM-COATED TABLET 150MG

February 14, 2017

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09CA04

irbesartan

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Macleods Pharmaceuticals Limited

Active Ingredients

Irbesartan

150.00mg

Irbesartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ERBETAN FILM-COATED TABLET 150MG - HSA Approval | MedPath